This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury

This study has been terminated.
(Based on a business decision unrelated to any safety concerns.)
Sponsor:
Information provided by (Responsible Party):
StemCells, Inc.
ClinicalTrials.gov Identifier:
NCT02163876
First received: June 12, 2014
Last updated: May 31, 2016
Last verified: May 2016
  Purpose
This study will evaluate the safety and efficacy of human central nervous system stem cell transplantation into patients with traumatic injury in the cervical region of the spinal cord.

Condition Intervention Phase
Cervical Spinal Cord Injury Spine Injury Cervical Spine Injury Drug: HuCNS-SC cells Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Single-Blind, Randomized, Parallel Arm, Phase II Proof-of-Concept Study of the Safety and Efficacy of Human Central Nervous System Stem Cells (HuCNS-SC) Transplantation in Cervical Spinal Cord Injury

Resource links provided by NLM:


Further study details as provided by StemCells, Inc.:

Primary Outcome Measures:
  • Change from baseline in ISNCSCI upper extremity motor scores [ Time Frame: Up to one year after enrollment ]

Secondary Outcome Measures:
  • Number of participants with serious and non-serious adverse events [ Time Frame: Up to one year from the time of enrollment ]
    Safety measures will include collection of adverse events, laboratory tests, neurological examination, ISNCSCI motor and sensory scores, pain and allodynia assessment, AIS grade, physical examination and modified Ashworth scale


Enrollment: 31
Study Start Date: October 2014
Study Completion Date: May 2016
Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: HuCNS-SC cells
Intramedullary transplantation of HuCNS-SC cells in the cervical spine
Drug: HuCNS-SC cells
surgery arm
Other Names:
  • human neural stem cells
  • HuCNS-SC
  • HCNS-SC
No Intervention: non-surgery arm
non-surgery arm

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male or female subjects age 18 to 60 years.
  • Traumatic cervical spinal cord injury (cSCI) with C5-C7 motor levels according to the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) as determined by the Investigator.
  • American Spinal Injury Association Impairment Scale (AIS) Grades B or C
  • Minimum of 12 weeks post-injury prior to Screening

Exclusion Criteria:

  • History of penetrating SCI.
  • MRI evidence of complete spinal cord interruption .
  • Evidence of spinal instability, stenosis and/or persistent cord compression related to the initial trauma.
  • Prior participation in another investigational study within 90 days prior to Screening.
  • Previous organ, tissue, bone marrow transplantation, or gene transfer
  • History of malignancy (except non-melanoma skin cancers) that require(d) radiation and/or chemotherapy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02163876

Locations
United States, California
Rancho Los Amigos National Rehabilitation Center/USC
Downey, California, United States, 90242
United States, Florida
University of Miami Miller School of Medicine
Miami, Florida, United States, 33136
United States, Illinois
Northwestern University
Chicago, Illinois, United States, 60611
United States, Maryland
University of Maryland Medical Systems
Baltimore, Maryland, United States, 21201
United States, Michigan
University of Michigan Health System
Ann Arbor, Michigan, United States, 48109
United States, Minnesota
University of Minnesota/Courage Kenny Rehabilitation Institute
Minneapolis, Minnesota, United States, 55414
United States, New York
Mount Sinai Medical Center, Dept of Neurosurgery
New York, New York, United States, 10029
United States, Pennsylvania
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213
United States, Texas
University of Texas, Mischer Neuroscience Institute
Houston, Texas, United States, 77030
United States, Utah
University of Utah Health Sciences Center
Salt Lake City, Utah, United States, 84132
United States, Wisconsin
Medical College of Wisconsin/Froedtert Hospital
Milwaukee, Wisconsin, United States, 53226
Canada, Alberta
Foothills Medical Center
Calgary, Alberta, Canada, T2N 2T9
Canada, Ontario
Toronto Western Hospital
Toronto, Ontario, Canada, M9R1L5
Sponsors and Collaborators
StemCells, Inc.
Investigators
Study Director: Stephen Huhn, MD StemCells, Inc.
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: StemCells, Inc.
ClinicalTrials.gov Identifier: NCT02163876     History of Changes
Other Study ID Numbers: CL-SCI-201
Study First Received: June 12, 2014
Last Updated: May 31, 2016

Keywords provided by StemCells, Inc.:
spine
injury
trauma
spine injury
cervical spine injury
cervical spine
stemcells transplantation

Additional relevant MeSH terms:
Wounds and Injuries
Spinal Cord Injuries
Spinal Injuries
Spinal Cord Diseases
Central Nervous System Diseases
Nervous System Diseases
Trauma, Nervous System
Back Injuries

ClinicalTrials.gov processed this record on July 21, 2017